Contineum Therapeutics, Inc. (CTNM)

13.44 -0.01 (-0.07%) USD  |  NASDAQ  |  Apr 02, 16:00
13.47 +0.03 (+0.22%) After-Hours: 20:00
More

Contineum Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for CTNM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Coherus Oncology, Inc. Upgrade
ALX Oncology Holdings, Inc. Upgrade
Century Therapeutics, Inc. Upgrade
Climb Bio, Inc. Upgrade
PepGen Inc. Upgrade